Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low-Molecular-Weight Heparin-Induced Hepatotoxicity-Reference-Cited by-同舟云学术

Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low-Molecular-Weight Heparin-Induced Hepatotoxicity

Published:2001-01 Issue:1 Volume:21 Page:108-113
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Carlson Melissa K.,Gleason Patrick P.,Sen Soma

Publisher

Wiley

Subject

Pharmacology (medical)

Reference21 articles.

1. Low molecular weight heparin

2. A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous Thrombosis

3. Treatment of Venous Thromboembolism with Low Molecular Weight Heparins

4. A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Verification of selective and individual pulmonary thromboembolism prophylaxes for cesarean delivery;Obstetrics & Gynecology Science;2023-05-15

2. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review;World Journal of Gastroenterology;2022-12-21

3. Comparison of the hepatotoxicity of low-molecular-weight versus unfractionated heparin for anticoagulation therapy after digital replantation;Archives of Hand and Microsurgery;2022-09-01

4. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy;Vaccines;2022-01-26

5. Efficacy and safety of edoxaban tosylate hydrate 15 mg in the prevention of venous thromboembolism in patients with impaired renal function after orthopedic surgery of the lower extremities;Renal Replacement Therapy;2021-12